Group One Trading
KRYS icon

Group One Trading’s Krystal Biotech KRYS Stock Holding History

Group One Trading’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-160
Closed -$33.7K – 8678
2025
Q3 		$28.2K Buy
+160
New +$23.9K ﹤0.01% 6419
2024
Q2 		– Sell
-1,192
Closed -$200K – 7122
2024
Q1 		$212K Buy
+1,192
New +$166K ﹤0.01% 3516
2022
Q1 		– Sell
-465
Closed -$29K – 8361
2021
Q4 		$33K Buy
+465
New +$27.1K ﹤0.01% 6637
2021
Q2 		– Sell
-556
Closed -$38.8K – 8348
2021
Q1 		$43K Buy
556
+156
+39% +$11.3K ﹤0.01% 6331
2020
Q4 		$24K Hold
400
– – ﹤0.01% 5418
2020
Q3 		$17K Buy
400
+100
+33% +$4.34K ﹤0.01% 5204
2020
Q2 		$12K Buy
+300
New +$14.4K ﹤0.01% 5048

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's KRYS Position: Q4 2025 in Review

Group One Trading sold out of Krystal Biotech (KRYS) in Q4 2025, closing a stake of 160 shares — an estimated $33.7K sold.

Group One Trading first reported a position in KRYS in Q2 2020 and held it in 7 quarters. The position peaked at $212K in Q1 2024. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • Group One Trading reported no remaining Krystal Biotech position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 160 Krystal Biotech shares in Q4 2025, an estimated $33.7K.
  • Group One Trading first reported a position in Krystal Biotech in Q2 2020 and held it in 7 quarters.
  • Group One Trading's Krystal Biotech position peaked at $212K in Q1 2024.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.